McGuire AL
Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, Texas.
ArticlePsychedelics
The Psychedelic Therapies Executive Order: On Approval and Clinical Readiness.
ArticleIbogaine
Toward a nuanced framework for the medical development of ibogaine and its analogues and derivatives: implications for psychopharmacology.
ArticleKetamine
When Off-Label Ketamine Meets Direct-to-Consumer Telehealth: Liability Risks and Ethical Responsibilities.
ArticlePsilocybin
Reported Safety Practices of Publicly Advertised Psychedelic Retreats.
ArticlePsilocybin
From trials to clinics: investigators' perspectives on translating psychedelic research into clinical care.
ArticlePsilocybin
Real-world use of classic and non-classic psychedelics in Hispanic/Latino adults with obsessive-compulsive disorder: international findings from the LATINO Study.
ArticlePsilocybin
A landscape analysis of psychedelic retreat organizations advertising online.
ArticlePsychedelics
On Minimizing Risk and Harm in the Use of Psychedelics.
ArticleMDMA